INHIBITION OF BRAIN TYPE-A MONOAMINE-OXIDASE AND 5-HYDROXYTRYPTAMINE UPTAKE BY 2 AMPHETAMINE METABOLITES, PARA-HYDROXYAMPHETAMINE AND PARA-HYDROXYNOREPHEDRINE

被引:28
作者
ARAI, Y
KIM, SK
KINEMUCHI, H
TADANO, T
SATOH, SE
SATOH, N
KISARA, K
机构
[1] SHOWA UNIV, SCH MED, DEPT PHARMACOL, TOKYO 142, JAPAN
[2] TOHOKU COLL PHARMACEUT SCI, DEPT PHARMACOL, SENDAI, MIYAGI 983, JAPAN
关键词
Amphetamine metabolites; Monoamine oxidase; Monoamine oxidase type A inhibition; p‐Hydroxyamphetamine; p‐Hydroxynorephedrine;
D O I
10.1111/j.1471-4159.1990.tb04151.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two amphetamine metabolites, p‐hydroxyam‐phetamine (p‐OHA) and p‐hydroxynorephedrine (p‐OHN), selectively inhibited the A form of monoamine oxidase (MAO) in rat and mouse forebrain homogenates. Of these two metabolites, p‐OHA inhibited MAO‐A more strongly than p‐OHN. This MAO‐A‐selective inhibition by p‐OHA or p‐OHN was found to be competitive with respect to deamination of its substrate, 5‐hydroxytryptamine (5‐HT). The degree of MAO‐A inhibition was not changed by 90 min of preincubation of the enzyme preparations with either metabolite, and the activity inhibited by p‐OHA after the preincubation recovered completely to the control level after repeated washing. Uptake of 5‐HT or dopamine into mouse forebrain synaptosomes was highly reduced by both p‐OHA and p‐OHN. Both metabolites were more potent in reducing dopamine uptake than in reducing 5‐HT uptake. In reduction of 5‐HT and of dopamine uptake, p‐OHA was more potent than p‐OHN. These results indicate that p‐OHA is a more selective inhibitor of brain MAO‐A activity and 5‐HT uptake than its subsequent metabolite, p‐OHN. These two actions of p‐OHA might, together with possible 5‐HT efflux into the synaptic cleft, greatly contribute to head twitch, a brain 5‐HT‐mediated animal behavior induced by p‐OHA. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:403 / 408
页数:6
相关论文
共 36 条
[1]   THE EXVIVO EFFECT OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) ON RAT INTRANEURONAL AND EXTRANEURONAL MONOAMINE-OXIDASE ACTIVITY [J].
ARAI, Y ;
TOYOSHIMA, Y ;
KINEMUCHI, H ;
TADANO, T ;
KISARA, K .
NEUROSCIENCE LETTERS, 1986, 70 (02) :266-271
[2]  
ARAI Y, 1985, BIOGENIC AMINES, V2, P65
[3]   STUDIES OF MONOAMINE-OXIDASE AND SEMICARBAZIDE-SENSITIVE AMINE OXIDASE .2. INHIBITION BY ALPHA-METHYLATED SUBSTRATE-ANALOG MONOAMINES, ALPHA-METHYLTRYPTAMINE, ALPHA-METHYLBENZYLAMINE AND 2 ENANTIOMERS OF ALPHA-METHYLBENZYLAMINE [J].
ARAI, Y ;
TOYOSHIMA, Y ;
KINEMUCHI, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 41 (02) :191-197
[5]  
AXELROD J, 1970, AMPHETAMINES RELATED, P207
[6]   ACCUMULATION OF 4-HYDROXYAMPHETAMINE BY RAT STRIATAL HOMOGENATES [J].
CHO, AK ;
SCHAEFFER, JC ;
FISCHER, JF .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (16) :1540-1542
[7]   ACCUMULATION OF P-HYDROXYAMPHETAMINE BY BRAIN HOMOGENATES AND ITS ROLE IN RELEASE OF CATECHOLAMINES [J].
CHO, AK ;
FISCHER, JF ;
SCHAEFFER, JC .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (15) :1367-1372
[8]  
FAGERVALL I, 1986, J NEUROCHEM, V47, P569
[9]  
FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203
[10]   MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].
FOWLER, CJ ;
CALLINGHAM, BA ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101